Influence of O.C.T. embedding compound on determinations of estrogen and progestin receptors in breast cancer.
Pasic R, Djulbegovic B, Wittliff JL
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine whether OCT compound is capable of interfering with ER and PR binding analyses. Case-matched biopsies of breast tumor were snap-frozen on dry ice in the presence or absence of OCT. Specimens were stored at -86 degrees C for 1-2 d prior to analysis.
Summary of Findings
Results of radioligand-binding assays for OCT-embedded and un-embedded case-matched controls were not significantly different for ER or PR, nor was either receptor status (threshold was set at 10 fmol/mg cytosol protein) altered by use of OCT for any of the specimens examined. Further, ER and PR binding capability and Kd values did not differ between 306 un-embedded biobanked specimens and 80 biopsies that were embedded in OCT, as determined by the ligand titration assay in both the presence and absence of sodium molybdate.
Biospecimens
TissueBreastPreservation Types
OCTFrozenDiagnoses
NeoplasticCarcinomaPlatforms
ProteinReceptor bindingPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation FrozenOCTReceptor binding Specific Reaction solution Sodium molybdate